XY Planning Network Inc. Has $908,000 Stake in UnitedHealth Group Incorporated $UNH

XY Planning Network Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 182.9% in the 2nd quarter, Holdings Channel reports. The fund owned 2,184 shares of the healthcare conglomerate’s stock after purchasing an additional 1,412 shares during the quarter. XY Planning Network Inc.’s holdings in UnitedHealth Group were worth $908,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. BayBridge Capital Group LLC boosted its holdings in UnitedHealth Group by 43.0% during the second quarter. BayBridge Capital Group LLC now owns 1,134 shares of the healthcare conglomerate’s stock valued at $471,000 after purchasing an additional 341 shares in the last quarter. Hudock Inc. lifted its position in UnitedHealth Group by 1.0% during the 2nd quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock worth $1,182,000 after buying an additional 28 shares in the last quarter. Arizona State Retirement System grew its stake in shares of UnitedHealth Group by 1.5% during the second quarter. Arizona State Retirement System now owns 251,862 shares of the healthcare conglomerate’s stock valued at $104,681,000 after purchasing an additional 3,679 shares during the last quarter. West Family Investments Inc. increased its stake in shares of UnitedHealth Group by 214.7% in the 2nd quarter. West Family Investments Inc. now owns 3,100 shares of the healthcare conglomerate’s stock valued at $1,288,000 after buying an additional 2,115 shares during the period. Finally, Bank OZK bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $268,000. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is investing nearly $1.5 billion in artificial intelligence to expand Optum Insight’s software capabilities, improve operating efficiency and create new growth opportunities. Can UnitedHealth’s AI Strategy Strengthen Optum Insight’s Growth?
• Positive Sentiment: Jim Cramer characterized UnitedHealth’s latest quarter as very strong and argued that the company continues to have profitable growth and a strong competitive position. Analysts tracked by Quiver Quantitative also have a median price target of $434.50, above the recent trading level. Jim Cramer Discusses UnitedHealth’s Profitable Growth
• Neutral Sentiment: UnitedHealth’s partial sale of its Florida WellMed primary-care clinic network to TPG brings in strategic capital while allowing UNH to retain an equity interest. Management was also expected to reaffirm its full-year earnings guidance, but investors are looking for evidence that the Optum turnaround is sustainable. UnitedHealth Sells WellMed to TPG
• Negative Sentiment: The TPG transaction raised concerns because the Florida WellMed operations have been associated with Optum Health’s recent profit problems. Investors questioned whether the deal signals a weaker outlook for the assets or reflects a need for outside capital during the turnaround. UnitedHealth Slips as TPG Buys Into Florida WellMed Clinics
• Negative Sentiment: Comments from CVS Health about continued high medical-cost growth pressured managed-care stocks, including UNH. UnitedHealth also continues to face commercial-insurance margin pressure, while parts of the Optum recovery remain incomplete. CVS Still Sees High-Trend Cost Growth
• Negative Sentiment: UnitedHealth trades at a substantial valuation premium to some managed-care peers despite having slower revenue growth, increasing sensitivity to disappointing guidance or execution. Broader healthcare-sector weakness added to the selling pressure. Why Is UNH Stock Trading at a Premium?

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. Mizuho upped their price target on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research note on Monday, July 20th. Erste Group Bank cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Piper Sandler set a $477.00 price target on UnitedHealth Group in a research report on Thursday, July 16th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Finally, Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

UnitedHealth Group Price Performance

NYSE:UNH opened at $393.11 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The firm has a market cap of $352.85 billion, a price-to-earnings ratio of 25.30, a P/E/G ratio of 1.51 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The firm’s 50-day simple moving average is $410.24 and its 200 day simple moving average is $366.95.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.